Castle biosciences presents award-winning abstract at acg 2024 demonstrating ability of its tissuecypher® test to significantly reduce healthcare costs associated with the management of barrett's esophagus patients

Friendswood, texas--(business wire)---- $cstl #acg2024--new data at acg 2024 demonstrates ability of tissuecypher to significantly reduce healthcare costs associated with management of barrett's esophagus.
CSTL Ratings Summary
CSTL Quant Ranking